Dr. Deyell is a pediatric oncologist/hematologist and clinician investigator at BC Children’s Hospital and Research Institute. She is a co-leader of the BC Pediatric Precision OncoGenomics study (PedsPOG) and of the Clinical Node for the national PRecision Oncology For Young peopLE (PROFYLE) program. She leads the Developmental Therapeutics program in pediatric oncology/hematology in BC, and participates in the national C17 DVL network.
ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma. Marr KC and Connors JM and Savage KJ and Goddard KJ and Deyell RJ DOI: 10.1093/annonc/mdx005 PubMed: 28327925 04/2017
ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Alassiri AH and Ali RH and Shen Y and Lum A and Strahlendorf C and Deyell R and Rassekh R and Sorensen PH and Laskin J and Marra M and Yip S and Lee CH and Ng TL DOI: 10.1097/pas.0000000000000677 PubMed: 27259007 08/2016
Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children. Görges M and West N and Deyell R and Winton P and Cheung W and Lauder G DOI: 10.1002/pbc.25197 PubMed: 25263424 01/2015
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project. Mossé YP and Deyell RJ and Berthold F and Nagakawara A and Ambros PF and Monclair T and Cohn SL and Pearson AD and London WB and Matthay KK DOI: 10.1002/pbc.24777 PubMed: 24038992 04/2014
Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. Pediatric Blood & Cancer DOI: 10.1002/pbc.24446 PubMed: 23281214 05/2013
Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia. Deyell RJ and Shereck EB and Milner RA and Schultz KR DOI: 10.3109/08880018.2011.568043 PubMed: 21707222 09/2011
Optimization of liposomal topotecan for use in treating neuroblastoma Cancer Medicine Lina Chernov and Rebecca J. Deyell and Malathi Anantha and Nancy Dos Santos and Roger Gilabert-Oriol and Marcel B. Bally DOI: 10.1002/cam4.1083 05/2017
Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma Pediatric Blood & Cancer Kristin Marr and Rebecca Ronsley and Helen Nadel and Kate Douglas and Sharon Gershony and Caron Strahlendorf and Jeffrey H. Davis and Rebecca J. Deyell DOI: 10.1002/pbc.28167 04/2020
Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors Pediatric Blood & Cancer Donna L. Johnston and Susan Zupanec and Darcy Nicksy and Daniel Morgenstern and Aru Narendran and Rebecca J. Deyell and Yvan Samson and Bing Wu and Sylvain Baruchel DOI: 10.1002/pbc.27676 06/2019
Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission Pediatric Blood & Cancer Ghada N. Al-Rawahi and Abeer Al-Najjar and Rachel McDonald and Rebecca J. Deyell and George R. Golding and Rollin Brant and Peter Tilley and Eva Thomas and Shahrad R. Rassekh and Aisling O'Gorman and Peggy Wong and Lucy Turnham and Simon Dobson DOI: 10.1002/pbc.27604 05/2019
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218 Pediatric Blood & Cancer Rebecca J. Deyell and Bing Wu and S. Rod Rassekh and Dongsheng Tu and Yvan Samson and Adam Fleming and Eric Bouffet and Xiaoqun Sun and Jean Powers and Lesley Seymour and Sylvain Baruchel and Daniel A. Morgenstern DOI: 10.1002/pbc.27540 03/2019
Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies. JNCI cancer spectrum Lorentzian A and Biegel JA and Ostrow DG and Rolf N and Liu CC and Rassekh SR and Deyell RJ and Triche T and Schultz KR and Rozmus J and Reid GSD and Lim CJ and Lange PF and Maxwell CA DOI: 10.1093/jncics/pky079 PubMed: 30976750 10/2018
Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer. JCO precision oncology Newton Y and Rassekh SR and Deyell RJ and Shen Y and Jones MR and Dunham C and Yip S and Leelakumari S and Zhu J and McColl D and Swatloski T and Salama SR and Ng T and Hendson G and Lee AF and Morozova O DOI: 10.1200/po.17.00198 PubMed: 31372595 04/2018
Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer. JCO precision oncology Newton Y and Rassekh SR and Deyell RJ and Shen Y and Jones MR and Dunham C and Yip S and Leelakumari S and Zhu J and McColl D and Swatloski T and Salama SR and Ng T and Hendson G and Lee AF and Morozova O 04/2018
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits. Scientific reports Alcaide M and Yu S and Davidson J and Albuquerque M and Bushell K and Fornika D and Arthur S and Grande BM and McNamara S and Tertre MCD and Batist G and Huntsman DG and Cavallone L and Morin RD DOI: 10.1038/s41598-017-10269-2 PubMed: 28874686 09/2017
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers. Laskin J and Jones S and Aparicio S and Chia S and Ch'ng C and Deyell R and Eirew P and Fok A and Gelmon K and Ho C and Huntsman D and Jones M and Kasaian K and Karsan A and Leelakumari S and Li Y and Lim H and Ma Y and Mar C and Martin M DOI: 10.1101/mcs.a000570 PubMed: 27148575 10/2015
Antidepressant use among survivors of childhood, adolescent, and young adult cancer: Letter to the editor response Pediatric Blood & Cancer Rebecca J. Deyell and Maria Lorenzi and John J. Spinelli and Mary L. McBride DOI: 10.1002/pbc.24885 2013
Costs and consequences of immunosuppressive therapy in children with aplastic anemia. Shereck EB and Deyell RJ and Kurre P DOI: 10.3324/haematol.2011.044917 PubMed: 21632841 06/2011
Low oxygen saturation by pulse oximetry may be associated with a low oxygen affinity hemoglobin variant, hemoglobin Titusville. Deyell R and Jackson S and Spier S and Le D and Poon MC DOI: 10.1097/01.mph.0000200685.33291.0a PubMed: 16462584 02/2006
Clinician Investigator Program, University of British Columbia, 2009-2011
Honours & Awards
John Snow Prize, Epidemiologic methods, University of British Columbia, November 2010
Laura MacRae Subspecialty Resident Award, BC Children’s Hospital, 2010
Human DNA testing could improve outcomes for patients with COVID-19.
That’s the key idea put forth in preliminary research posted this month to bioRxiv that highlights the potential benefits of testing COVID-19 patients for genetic variants of ACE2—the protein identified as the point-of-entry for the SARS-COV-2 virus into human cells.
Congratulations to the BC Children's and BC Women's investigators who were awarded funding through the highly competitive Canadian Institutes of Health Research (CIHR) Project Grant Fall 2019 competition.
A new study suggests that specialized immune cells that dampen inflammation and help repair the gut could be used as a potential therapy for children dealing with the painful symptoms of inflammatory bowel disease.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.